Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
PBF Energy
PBF
$8.2B
| $27.5M | 0.05% |
967,751
+513,155
| +113% | +$14.4M |
|
477
Travere Therapeutics
TVTX
$6.16B
| $27.5M | 0.05% |
829,574
-110,828
| -12% | -$3.04M |
|
|
APC
478
CALL
DELISTED
Anadarko Petroleum
APC
| $27.5M | 0.05% |
352,100
+161,400
| +85% | +$14M |
|
|
CSC
479
DELISTED
Computer Sciences
CSC
| $27.5M | 0.05% |
993,072
-2,035,927
| -67% | -$57M |
|
|
GRFS
480
Grifois
GRFS
$5.44B
| $27.5M | 0.05% |
1,773,676
-545,208
| -24% | -$8.84M |
|
481
Equifax
EFX
$22.8B
| $27.3M | 0.05% |
281,317
+68,081
| +32% | +$6.64M |
|
482
Marriott International
MAR
$93.7B
| $27.3M | 0.05% |
367,007
+324,664
| +767% | +$25.7M |
|
|
TSRO
483
DELISTED
TESARO, Inc.
TSRO
| $27.3M | 0.05% |
464,135
-23,899
| -5% | -$1.37M |
|
|
OCR
484
DELISTED
OMNICARE INC
OCR
| $27.3M | 0.05% |
289,256
+26,877
| +10% | +$2.4M |
|
|
KW
485
DELISTED
Kennedy-Wilson Holdings
KW
| $27.2M | 0.05% |
1,104,869
-404,080
| -27% | -$10.3M |
|
|
WFT
486
DELISTED
Weatherford International plc
WFT
| $27.1M | 0.05% |
2,210,230
-646,491
| -23% | -$8.98M |
|
487
Applied Materials
AMAT
$384B
| $27.1M | 0.05% |
1,410,813
+736,410
| +109% | +$15.1M |
|
488
Novartis
NVS
$300B
| $26.8M | 0.05% |
304,456
+91,858
| +43% | +$8.43M |
|
489
PUT
Invesco QQQ Trust
QQQ
$483B
| $26.4M | 0.05% |
246,900
+121,900
| +98% | +$13.3M |
|
490
Illinois Tool Works
ITW
$80.7B
| $26.4M | 0.05% |
287,746
+262,566
| +1,043% | +$25M |
|
491
OneMain Financial
OMF
$7.25B
| $26.3M | 0.05% |
+572,519
| New | +$27.8M |
|
|
XIFR
492
XPLR Infrastructure LP
XIFR
$1.07B
| $26.3M | 0.05% |
662,831
+138,172
| +26% | +$5.99M |
|
|
CERN
493
CALL
DELISTED
Cerner Corp
CERN
| $26.2M | 0.05% |
+380,000
| New | +$26.6M |
|
|
FMBI
494
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $26.2M | 0.05% |
1,382,215
-712,695
| -34% | -$12.8M |
|
|
PHH
495
DELISTED
PHH Corporation
PHH
| $26.2M | 0.05% |
1,006,446
-989,608
| -50% | -$25.9M |
|
496
Verizon
VZ
$208B
| $26.2M | 0.05% |
561,747
-5,543
| -1% | -$271K |
|
497
Radian Group
RDN
$4.85B
| $26.2M | 0.05% |
1,395,385
+1,029,563
| +281% | +$18.5M |
|
498
Sherwin-Williams
SHW
$84.2B
| $26.1M | 0.05% |
+285,105
| New | +$27M |
|
499
Expeditors International
EXPD
$24.3B
| $26.1M | 0.05% |
566,431
+238,094
| +73% | +$11.2M |
|
|
BLUE
500
DELISTED
bluebird bio
BLUE
| $26.1M | 0.05% |
11,965
-46,127
| -79% | -$94M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.